Nuvation Bio
(NYSE) NUVB
Nuvation Bio Financials at a Glance
Market Cap
$2.11B
Revenue (TTM)
$143.05M
Net Income (TTM)
-$145.99M
EPS (TTM)
-$0.43
P/E Ratio
-14.11
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$6.07
Volume
4,467
Open
$5.71
Price
$6.07
Volume
4,467
Open
$5.71
Previous Close
$6.04
Daily Range
$5.66 - $6.09
52-Week Range
$1.81 - $9.75
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$6.07
Volume
4,467
Open
$5.71
Previous Close
$6.04
Daily Range
$5.66 - $6.09
52-Week Range
$1.81 - $9.75
Estimated Earnings Date
Aug 6, 2026
NUVB News
NUVB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuvation Bio
Industry
Pharmaceuticals
Sector
Health CareEmployees
298
CEO
David T. Hung, MD
Website
www.nuvationbio.comHeadquarters
New York City, NY 10036, US
NUVB Financials
Key Financial Metrics (TTM)
Gross Margin
91.64%
Operating Margin
-104.99%
Net Income Margin
-102.06%
Return on Equity
-44.10%
Return on Capital
-67.45%
Return on Assets
-23.92%
Earnings Yield
-7.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.11B
Shares Outstanding
349.20M
Volume
4.47K
Avg. Volume
4.09M
Financials (TTM)
Gross Profit
$131.08M
Operating Income
-$150.18M
EBITDA
-$129.73M
Operating Cash Flow
-$125.73M
Capital Expenditure
-$330.00K
Free Cash Flow
-$126.06M
Cash & ST Invst.
$533.73M
Total Debt
$9.83M
Nuvation Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$83.23M
+2598.7%
Gross Profit
$77.61M
+7739.6%
Gross Margin
93.25%
N/A
Market Cap
$2.11B
N/A
Market Cap/Employee
$7.73M
N/A
Employees
273
N/A
Net Income
$5.40M
+110.1%
EBITDA
$12.64M
+123.9%
Quarterly Fundamentals
Total Cash
$533.73M
+15.6%
Total Debt
$9.83M
-13.9%
Accounts Receivable
$25.98M
+375.7%
Inventory
$15.84M
+113071.4%
Long Term Debt
$2.20M
-42.7%
Short Term Debt
$7.63M
+0.7%
Return on Assets
-23.92%
N/A
Return on Invested Capital
-28.30%
N/A
Free Cash Flow
$5.02M
+111.8%
Operating Cash Flow
$5.07M
+111.9%